Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.
Subscribe

Sci. STKE, 4 November 2003
Vol. 2003, Issue 207, p. pe49
[DOI: 10.1126/scisignal.2072003pe49]

PERSPECTIVES

Signal Transduction and Genes-to-Behaviors Pathways in Psychiatric Diseases

Husseini K. Manji1*, Irving I. Gottesman2*, and Todd D. Gould1*

lLaboratory of Molecular Pathophysiology, Mood and Anxiety Disorders Program, NIMH, Bethesda, MD 20892, USA.
2Department of Psychiatry, University of Minnesota Medical School, Minneapolis, MN 55454, USA.

Abstract: Although psychiatric diseases are among the most common and destructive of all human illnesses, the molecular and cellular mechanisms underlying their complex origins remain to be elucidated. Dysfunction of critical intracellular signaling pathways is very likely to be involved. This conclusion is based on a number of observations, including the short- and long-term cellular effects of psychiatric drugs; the critical role signaling pathways play in neurotransmitter, neuropeptide, and neurohormone communication; and the fact that signaling pathways are principle regulators of the diverse array of behavioral symptoms experienced by patients. The genomics era has brought to psychiatry an abundance of genetic linkage and candidate gene findings. The difficult task--now under way--is to discern the functional relevance of these results. Recent evidence suggests the involvement of the ubiquitous protein phosphatase 2B (calcineurin), a critical regulator of many signal transduction pathways, as a schizophrenia susceptibility gene. It is likely that genetic findings in severe psychiatric disorders will continue to implicate direct and indirect modulation of critical intracellular signaling pathways.

*Corresponding authors: E-mail:manjih{at}intra.nimh.nih.gov, gotte003{at}umn.edu, gouldt{at}intra.nimh.nih.gov

Citation: H. K. Manji, I. I. Gottesman, T. D. Gould, Signal Transduction and Genes-to-Behaviors Pathways in Psychiatric Diseases. Sci. STKE 2003, pe49 (2003).

Read the Full Text

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
Genetic analysis of the calcineurin pathway identifies members of the EGR gene family, specifically EGR3, as potential susceptibility candidates in schizophrenia.
K. Yamada, D. J. Gerber, Y. Iwayama, T. Ohnishi, H. Ohba, T. Toyota, J. Aruga, Y. Minabe, S. Tonegawa, and T. Yoshikawa (2007)
PNAS 104, 2815-2820
   Abstract »    Full Text »    PDF »
Life Stress, Genes, and Depression: Multiple Pathways Lead to Increased Risk and New Opportunities for Intervention.
D. S. Charney and H. K. Manji (2004)
Sci. STKE 2004, re5
   Abstract »    Full Text »    PDF »

To Advertise     Find Products

Science Signaling. ISSN 1937-9145 (online), 1945-0877 (print). Pre-2008: Science's STKE. ISSN 1525-8882